» Articles » PMID: 29746667

A Fluorescent Reporter for Quantification and Enrichment of DNA Editing by APOBEC-Cas9 or Cleavage by Cas9 in Living Cells

Overview
Specialty Biochemistry
Date 2018 May 11
PMID 29746667
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Base editing is an exciting new genome engineering technology. C-to-T mutations in genomic DNA have been achieved using ribonucleoprotein complexes comprised of rat APOBEC1 single-stranded DNA deaminase, Cas9 nickase (Cas9n), uracil DNA glycosylase inhibitor (UGI), and guide (g)RNA. Here, we report the first real-time reporter system for quantification of APOBEC-mediated base editing activity in living mammalian cells. The reporter expresses eGFP constitutively as a marker for transfection or transduction, and editing restores functionality of an upstream mCherry cassette through the simultaneous processing of two gRNA binding regions that each contain an APOBEC-preferred 5'TCA target site. Using this system as both an episomal and a chromosomal editing reporter, we show that human APOBEC3A-Cas9n-UGI and APOBEC3B-Cas9n-UGI base editing complexes are more efficient than the original rat APOBEC1-Cas9n-UGI construct. We also demonstrate coincident enrichment of editing events at a heterologous chromosomal locus in reporter-edited, mCherry-positive cells. The mCherry reporter also quantifies the double-stranded DNA cleavage activity of Cas9, and may therefore be adaptable for use with many different CRISPR systems. The combination of a rapid, fluorescence-based editing reporter system and more efficient, structurally defined DNA editing enzymes broadens the versatility of the rapidly expanding toolbox of genome editing and engineering technologies.

Citing Articles

A real-time biochemical assay for quantitative analyses of APOBEC-catalyzed DNA deamination.

Belica C, Carpenter M, Chen Y, Brown W, Moeller N, Boylan I J Biol Chem. 2024; 300(6):107410.

PMID: 38796062 PMC: 11234013. DOI: 10.1016/j.jbc.2024.107410.


A real-time biochemical assay for quantitative analyses of APOBEC-catalyzed DNA deamination.

Belica C, Carpenter M, Chen Y, Brown W, Moeller N, Boylan I bioRxiv. 2024; .

PMID: 38766133 PMC: 11100776. DOI: 10.1101/2024.05.11.593688.


Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.

Sanchez A, Ortega P, Sakhtemani R, Manjunath L, Oh S, Bournique E Nat Commun. 2024; 15(1):2370.

PMID: 38499542 PMC: 10948877. DOI: 10.1038/s41467-024-45909-5.


APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels.

Rieffer A, Chen Y, Salamango D, Moraes S, Harris R CRISPR J. 2023; 6(5):430-446.

PMID: 37672599 PMC: 10611974. DOI: 10.1089/crispr.2023.0027.


Enrichment strategies to enhance genome editing.

Mikkelsen N, Bak R J Biomed Sci. 2023; 30(1):51.

PMID: 37393268 PMC: 10315055. DOI: 10.1186/s12929-023-00943-1.


References
1.
Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M . Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science. 2016; 353(6305). DOI: 10.1126/science.aaf8729. View

2.
Kim D, Lim K, Kim S, Yoon S, Kim K, Ryu S . Genome-wide target specificities of CRISPR RNA-guided programmable deaminases. Nat Biotechnol. 2017; 35(5):475-480. DOI: 10.1038/nbt.3852. View

3.
Pham P, Afif S, Shimoda M, Maeda K, Sakaguchi N, Pedersen L . Activation-induced deoxycytidine deaminase: Structural basis for favoring WRC hot motif specificities unique among APOBEC family members. DNA Repair (Amst). 2017; 54:8-12. PMC: 6408873. DOI: 10.1016/j.dnarep.2017.03.007. View

4.
Conticello S . The AID/APOBEC family of nucleic acid mutators. Genome Biol. 2008; 9(6):229. PMC: 2481415. DOI: 10.1186/gb-2008-9-6-229. View

5.
Harris R, Dudley J . APOBECs and virus restriction. Virology. 2015; 479-480:131-45. PMC: 4424171. DOI: 10.1016/j.virol.2015.03.012. View